Annual Accounts Receivable
N/A
December 31, 2023
Summary
- MED annual accounts receivable is not available.
Performance
MED Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- MED quarterly accounts receivable is not available.
Performance
MED Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MED Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MED Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Medifast Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $88.00 K(-86.4%) |
| Sep 2020 | - | $647.00 K(-22.6%) |
| Jun 2020 | - | $836.00 K(+114.4%) |
| Mar 2020 | - | $390.00 K(-72.9%) |
| Dec 2019 | $1.44 M(+42.1%) | $1.44 M(-1.0%) |
| Sep 2019 | - | $1.45 M(+48.4%) |
| Jun 2019 | - | $978.00 K(+55.0%) |
| Mar 2019 | - | $631.00 K(-37.6%) |
| Dec 2018 | $1.01 M(+75.5%) | $1.01 M(-0.6%) |
| Sep 2018 | - | $1.02 M(+8.9%) |
| Jun 2018 | - | $934.00 K(-8.9%) |
| Mar 2018 | - | $1.02 M(+78.0%) |
| Dec 2017 | $576.00 K(-58.5%) | $576.00 K(-18.6%) |
| Sep 2017 | - | $708.00 K(-22.5%) |
| Jun 2017 | - | $914.00 K(-38.8%) |
| Mar 2017 | - | $1.49 M(+7.6%) |
| Dec 2016 | $1.39 M(-15.1%) | $1.39 M(+22.6%) |
| Sep 2016 | - | $1.13 M(-30.5%) |
| Jun 2016 | - | $1.63 M(-23.1%) |
| Mar 2016 | - | $2.12 M(+29.5%) |
| Dec 2015 | $1.63 M(-1.0%) | $1.63 M(-12.6%) |
| Sep 2015 | - | $1.87 M(-6.1%) |
| Jun 2015 | - | $1.99 M(-13.7%) |
| Mar 2015 | - | $2.31 M(+39.8%) |
| Dec 2014 | $1.65 M(+75.2%) | $1.65 M(-29.9%) |
| Sep 2014 | - | $2.35 M(+39.0%) |
| Jun 2014 | - | $1.69 M(+11.1%) |
| Mar 2014 | - | $1.52 M(+61.8%) |
| Dec 2013 | $942.00 K(-56.1%) | $942.00 K(-51.2%) |
| Sep 2013 | - | $1.93 M(-1.7%) |
| Jun 2013 | - | $1.97 M(-19.9%) |
| Mar 2013 | - | $2.45 M(+14.2%) |
| Dec 2012 | $2.15 M(+45.4%) | $2.15 M(-21.4%) |
| Sep 2012 | - | $2.73 M(+14.1%) |
| Jun 2012 | - | $2.40 M(+10.0%) |
| Mar 2012 | - | $2.18 M(+47.4%) |
| Dec 2011 | $1.48 M(+137.1%) | $1.48 M(-4.3%) |
| Sep 2011 | - | $1.54 M(+34.6%) |
| Jun 2011 | - | $1.15 M(+40.7%) |
| Mar 2011 | - | $815.00 K(+30.8%) |
| Dec 2010 | $623.00 K | $623.00 K(-27.9%) |
| Sep 2010 | - | $864.00 K(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $1.00 M(-8.8%) |
| Mar 2010 | - | $1.10 M(+62.9%) |
| Dec 2009 | $676.00 K(+50.9%) | $676.00 K(-3.0%) |
| Sep 2009 | - | $697.00 K(+19.8%) |
| Jun 2009 | - | $582.00 K(+1.4%) |
| Mar 2009 | - | $574.00 K(+28.1%) |
| Dec 2008 | $448.00 K(-9.1%) | $448.00 K(-7.1%) |
| Sep 2008 | - | $482.00 K(+1.7%) |
| Jun 2008 | - | $474.00 K(-0.2%) |
| Mar 2008 | - | $475.00 K(-3.7%) |
| Dec 2007 | $493.00 K(+10.0%) | $493.00 K(+16.0%) |
| Sep 2007 | - | $425.00 K(+2.2%) |
| Jun 2007 | - | $416.00 K(-20.8%) |
| Mar 2007 | - | $525.00 K(+17.2%) |
| Dec 2006 | $448.00 K(-54.5%) | $448.00 K(-41.4%) |
| Sep 2006 | - | $764.00 K(+6.6%) |
| Jun 2006 | - | $717.00 K(-7.5%) |
| Mar 2006 | - | $775.00 K(-21.3%) |
| Dec 2005 | $985.00 K(-7.3%) | $985.00 K(-35.1%) |
| Sep 2005 | - | $1.52 M(+33.4%) |
| Jun 2005 | - | $1.14 M(-1.9%) |
| Mar 2005 | - | $1.16 M(+9.0%) |
| Dec 2004 | $1.06 M(+65.8%) | $1.06 M(-5.6%) |
| Sep 2004 | - | $1.13 M(+6.4%) |
| Jun 2004 | - | $1.06 M(+34.3%) |
| Mar 2004 | - | $788.00 K(+22.9%) |
| Dec 2003 | $641.00 K(+125.7%) | $641.00 K(+12.9%) |
| Sep 2003 | - | $568.00 K(-9.6%) |
| Jun 2003 | - | $628.00 K(+180.4%) |
| Mar 2003 | - | $224.00 K(-21.1%) |
| Dec 2002 | $284.00 K(+0.4%) | $284.00 K(+5.6%) |
| Sep 2002 | - | $269.00 K(-25.5%) |
| Jun 2002 | - | $361.00 K(+51.0%) |
| Mar 2002 | - | $239.00 K(-15.5%) |
| Dec 2001 | $283.00 K(+12.3%) | $283.00 K(-18.7%) |
| Sep 2001 | - | $348.00 K(-3.1%) |
| Jun 2001 | - | $359.00 K(-23.5%) |
| Mar 2001 | - | $469.00 K(+86.1%) |
| Dec 2000 | $252.00 K(-18.2%) | $252.00 K |
| Dec 1999 | $308.00 K(-90.8%) | - |
| Dec 1998 | $3.34 M(+200.4%) | - |
| Dec 1997 | $1.11 M(-29.3%) | - |
| Dec 1996 | $1.57 M | - |
FAQ
- What is the all time high annual accounts receivable for Medifast?
- What is the all time high quarterly accounts receivable for Medifast?
What is the all time high annual accounts receivable for Medifast?
Medifast all-time high annual accounts receivable is $3.34 M
What is the all time high quarterly accounts receivable for Medifast?
Medifast all-time high quarterly accounts receivable is $2.73 M